Wednesday, October 14, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleCrunchbase News

The Sales Test This Norwest Partner Gives Founders Before He’ll Invest

View original at news.crunchbase.com
Crunchbase News - Funding Ma Title: The Sales Test This Norwest Partner Gives Founders Before He’ll Invest Date: 2026-09-09 11:00 Source: https://news.crunchbase.com/venture/startup-investment-qa-ai-hr-fintech-jacobsohn-norwest/ <p><a href="https://www.crunchbase.com/person/sean-jacobsohn">Sean Jacobsohn</a> worked at…
Opening lines of the source · Crunchbase News · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Before investing, Jacobsohn goes on sales calls with the CEO to assess the founder's selling ability, which he considers a major indicator of a company's potential.

    60% confidence
  • AI should not be trusted to perform calculations in finance because it is not good at math and errors can occur.

    60% confidence
  • It would be very hard to disrupt the core products of Workday, ADP, SAP, UKG and Dayforce, but easier to disrupt their secondary, non-core products.

    60% confidence
  • Jacobsohn built the Failure Museum, containing more than 1,500 items from failed companies and products, to study why they failed.

    60% confidence
  • Because CFOs buy software for themselves with one less layer of approval, it is easier to replace that software when the CFO is the direct buyer.

    60% confidence
  • There is a potential opportunity to disrupt NetSuite and Sage in ERP, with disruption happening more downmarket first before moving upmarket.

    60% confidence
  • Norwest's Office of the CFO market map has more than 500 companies, about three-quarters of which are legacy players.

    60% confidence
  • Norwest's primary entry point is seed and Series A, with opportunistic participation in later Series B and C deals.

    60% confidence
  • Jacobsohn has passed on CEOs/startups when the founder was consistently unable to secure second meetings on sales calls.

    60% confidence
  • An acquisition for less than $1 billion can still be a great outcome given Norwest's early entry point and typical acquirer budgets.

    60% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,375 source documents archived
Query this data → isubstrate.com